Clinical Trial Update: A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial of 2-deoxyglucose for advanced cancer and hormone-refractory prostate cancer was terminated; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 2-deoxyglucose (2-deoxyglucose)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-01-07